S. Hammond

发表

Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies

Jessica S. Little, Z. Weiss, S. Hammond, 2021, Journal of fungi.

Virologic Characterization of HIV Type 1 With a Codon 70 Deletion in Reverse Transcriptase

D. Kuritzkes, H. Hatano, Zixin Hu, 2007, Journal of acquired immune deficiency syndromes.

Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.

H. Masur, J. Wingard, H. Torres, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk of Latent Tuberculosis Reactivation after Hematopoietic-Cell Transplantation.

F. Marty, M. Cheng, L. Baden, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer.

M. Somerfield, S. Ramsey, E. Ludwig, 2022, JCO oncology practice.

Hepatitis B virus screening and potential reactivation in patients undergoing treatment for cancer.

S. Swaminathan, L. Baden, W. Bensinger, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

BK virus disease after allogeneic stem cell transplantation: a cohort analysis.

R. Soiffer, F. Marty, L. Baden, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

BK polyomavirus reactivation after reduced-intensity double umbilical cord blood cell transplantation.

K. Ballen, V. Boussiotis, F. Marty, 2015, Transplant immunology.

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation.

H. Einsele, F. Marty, M. Cheng, 2018, Blood advances.

Safety and Efficacy of PD‐1 Inhibitors Among HIV‐Positive Patients With Non–Small Cell Lung Cancer

D. Costa, F. Marty, M. Cheng, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Antibiotic prophylaxis for patients with acute leukemia

L. Baden, S. Hammond, 2008, Leukemia & lymphoma.

A eulogy for Dr Francisco Miguel Marty Forero

S. Koo, M. Cheng, J. Hill, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Clinical decisions. Management of skin and soft-tissue infection--polling results.

L. Baden, S. Hammond, 2008, The New England journal of medicine.

Use of triazoles for the treatment of invasive aspergillosis: A three‐year cohort analysis

I. Solomon, S. Koo, F. Marty, 2020, Mycoses.

Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience

F. Marty, D. Sutton, S. Hammond, 2015, Open forum infectious diseases.

A multicenter, retrospective, case‐cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients

K. Ballen, D. Braun, D. Leffler, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia

L. Baden, S. Hammond, 2007, Current hematologic malignancy reports.

The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study

F. Marty, A. Mohareb, S. Hammond, 2022, Open forum infectious diseases.

Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods

R. Gelman, W. Marasco, F. Marty, 2012, Journal of Clinical Microbiology.

Low incidence of invasive fungal disease following CD19 chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma

C. Jacobson, S. Koo, F. Marty, 2022, Blood advances.

Erratum: Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease [J Antimicrob Chemother, 72, (2017) (3406-3413)] doi: 10.1093/jac/dkx263

H. Waskin, H. Ostermann, J. Maertens, 2017 .

Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009

F. Marty, L. Baden, S. Hammond, 2011, Antimicrobial Agents and Chemotherapy.

The Promise of Direct-Acting Antiviral Therapies to Improve Care and Outcomes in Patients With Cancer Who Have Chronic Hepatitis C Infection.

S. Hammond, Yiannis Koullias, 2019, Journal of oncology practice.

Invasive fungal disease in patients treated for newly diagnosed acute leukemia

D. DeAngelo, F. Marty, L. Baden, 2010, American journal of hematology.

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.

A. Sabichi, M. Somerfield, N. Terrault, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy.

K. Reddy, Y. Falck‐Ytter, K. Beavers, 2015, Gastroenterology.

Infections in composite tissue allograft recipients.

S. Hammond, 2013, Infectious disease clinics of North America.

SOLAR ULTRAVIOLET RADIATION AND THE RISK OF INFECTIOUS DISEASE: SUMMARY OF A WORKSHOP * †

J. Frederick, P. Hersey, F. Noonan, 1995, Photochemistry and photobiology.

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

H. Waskin, H. Ostermann, J. Maertens, 2017, The Journal of antimicrobial chemotherapy.

Isavuconazole Treatment of a Patient with Disseminated Mucormycosis

R. Soiffer, F. Marty, S. Hammond, 2014, Journal of Clinical Microbiology.

Invasive fungal disease after remote inoculation in transplant recipients.

D. Milner, R. Soiffer, F. Marty, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular Methods To Improve Diagnosis and Identification of Mucormycosis

D. Milner, F. Marty, L. Baden, 2011, Journal of Clinical Microbiology.

First Reported Case of Invasive Cutaneous Penicillium cluniae Infection in a Patient With Acute Myelogenous Leukemia: A Case Report and Literature Review

J. Branda, A. Fathi, C. Cañete-Gibas, 2021, Open forum infectious diseases.

Serum Galactomannan and (1→3)-β-d-Glucan Assays for Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia

I. Ghobrial, M. Finkelman, S. Koo, 2011, Journal of Clinical Microbiology.

The COVID‐19 pandemic: A community approach

J. Schold, J. Azzi, P. Cravedi, 2020, Clinical transplantation.

Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.

C. Ukomadu, F. Marty, L. Baden, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors

E. Winer, F. Marty, S. Tolaney, 2015, Breast Cancer Research and Treatment.

Hepatitis B virus vaccination after allogeneic hematopoietic cell transplantation prevents post-transplant HBV reactivation.

F. Marty, V. Ho, S. Hammond, 2022, Transplantation and cellular therapy.

Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis

A. Fuhlbrigge, F. Marty, H. Goldberg, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Adverse Effects of Low-Dose Methotrexate

Anna E. Rutherford, N. Paynter, P. Ridker, 2020, Annals of Internal Medicine.

Letermovir and tacrolimus interaction effects in hematopoietic cell transplantation recipients receiving moderate cytochrome P450 3A4 inhibitors for antifungal prophylaxis.

Z. DeFilipp, Yi-Bin Chen, S. Hammond, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Infections Following Facial Composite Tissue Allotransplantation—Single Center Experience and Review of the Literature

B. Pomahac, S. Koo, F. Marty, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cytomegalovirus Infection Among Cord Blood Allogeneic Transplantation Recipients: Low Incidence of Cytomegalovirus Events without High-Dose Valacyclovir Prophylaxis.

R. Soiffer, S. Koo, F. Marty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk of hepatitis B virus reactivation in patients treated with ibrutinib.

M. Davids, F. Marty, Kaiwen Chen, 2018, Blood.

Opportunistic Infections (OIs) in Patients with Hematologic Malignancies (HM) Treated with Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study

Jennifer R. Brown, F. Marty, L. Baden, 2017, Open Forum Infectious Diseases.

Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection.

D. Costa, F. Marty, M. Awad, 2020, Lung cancer.

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients

C. Jacobson, L. Baden, Jessica S. Little, 2023, Transplantation and Cellular Therapy.

Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation

S. Koo, F. Marty, L. Baden, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Novel Coronavirus Disease (COVID-19) Threat for Patients With Cardiovascular Disease and Cancer

S. Ganatra, A. Nohria, S. Hammond, 2020, JACC: CardioOncology.

Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation

J. Laubach, P. Richardson, F. Marty, 2018, Bone Marrow Transplantation.

Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib

S. Treon, J. Castillo, M. Cheng, 2018, British journal of haematology.

European Society of Clinical Microbiology and Infectious Diseases, 25th European Congress of Clinical Microbiology and Infectious Diseases: Advisor's Introduction

S. Hammond, 2015 .

An Avid Imitator

Michael B. Miller, J. Krane, L. Baden, 2016, Journal of clinical medicine research.

Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.

P. Armand, S. Koo, F. Marty, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Novel Approach to Equitable Distribution of Scarce Therapeutics

M. Utku Ünver, Parag A. Pathak, P. Pathak, 2021, Chest.

Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity

S. Koo, S. Hammond, J. Manne-Goehler, 2023, Pilot and Feasibility Studies.

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy

M. Siedner, J. Sparks, J. Lemieux, 2023, medRxiv.

Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now

Jessica S. Little, Z. Weiss, S. Hammond, 2023, Expert review of anti-infective therapy.

Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia.

D. Milner, D. DeAngelo, L. Baden, 2011, Clinical lymphoma, myeloma & leukemia.

American Gastroenterological Association Institute Guideline on 1 the Prevention and Treatment of Hepatitis B Reactivation During 2 Immunosuppressive Drug Therapy

K. Reddy, K. Beavers, Joseph K. Lim, 2014 .